Connecting to LinkedIn...

W1siziisijiwmtuvmdqvmtuvmdgvntqvmzgvnzi1l01ptlrbu0hfqkxpr19vtljftkrfukvex0lnqudfx3jlc2l6zwrfyw5kx3jlbmrlcmvklmpwzyjdlfsiccisinrodw1iiiwimtkymhgxmjuwiyjdxq

Blog

Will Boston And San Francisco Continue To Dominate Biotech Innovation?

16/05/2014 by

W1siziisijiwmtqvmtavmjgvmtuvndivmdyvoty1l2zpbguixsxbinailcj0ahvtyiisijywmhg0mdbcdtawm2uixv0

When you look at the investment capital deployed toward Biotech start-ups in Boston and San Francisco, you might wonder what these two cities are doing to capture nearly half the invested venture capital available in 2013, while other cities lag far behind. We note that according to the National Venture Capital Association and Thomson Reuter’s research, these two cities captured 47 % of all invested biotech capital, and also led in the number of deals financed.

San Francisco edged out Boston in total invested capital in 2013, $1.15 Billion to $933 million, however Boston led in the previous two years. The two cities have battled back and forth for the top spot in recent years, and if you are one of the other 15 cities cited in the NVCA report, you’ve got a high mountain to climb to challenge these top contenders. San Diego comes in third with $387 million invested capital and the slide south is pretty steep from there. Washington, D.C, comes in fourth with all its federal life science grants, followed by Oakland California. It’s very revealing to learn that three of the top five cities are in California. While New York City comes in a distant seventh.

It isn’t just invested capital that makes the top two cities dominant in biotech; it’s their triple play, a confluence of human capital, infrastructure and financial capital which is responsible for the powerful dominance of Boston and San Francisco.

This article has been extracted from http://www.forbes.com,  please click on this link to read the article in full http://www.forbes.com/sites/kaykoplovitz/2014/05/15/will-boston-and-san-francisco-continue-to-dominate-biotech-innovation/

Montash is a multi-award winning, global IT recruitment firm. Specialising in permanent and contract positions across mid-senior appointments which cover a wide range of industry sectors and IT functions, including:

ERP, BI & Data, Information Security, IT Architecture & Strategy, Scientific Technologies, Demand IT and Business Engagement, Digital and E-commerce, Infrastructure and Service Delivery, Project and Programme Delivery.

With offices based in London, Montash has completed assignments in over 30 countries and has appointed technical professionals from board level to senior and mid-management in permanent and contract roles.

For more information please visit www.montash.com

comments powered by Disqus

Social Stream

Latest News

W1siziisijiwmtcvmdkvmjkvmdgvmtmvmjkvmjgyl1vudgl0bgvkigrlc2lnbiaomjuplmpwzyjdlfsiccisinrodw1iiiwimzgwedewmcmixv0

Are PSLs a Blocker or an Enabler?

2017-10-02 11:00:00 +0100

The use of a Preferred Supplier List (PSL) was intended to support and strengthen relationships and performance between organisations and their third party suppliers. As the technical landscape continues to evolve at rapid rate recruitment and demand for new skills becomes more intense. Are PSLs still the solution or an obstacle to sourcing the right talent? The traditional PSL A dedicated list of partners intended to guarantee quality and availability ...

W1siziisijiwmtcvmdkvmjevmdgvndmvmduvmtmxl1vudgl0bgvkigrlc2lnbiaomjmplmpwzyjdlfsiccisinrodw1iiiwimzgwedewmcmixv0

Why do we punish the victims of hacking?

2017-09-21 09:00:00 +0100

Hacks occur every 39 seconds, with 95% of them targeting governments, retailers and the tech industry. If the hackers are caught, they'll face prison time under the Computer Misuse Act. More often than not, the businesses who are victims of those attacks expose themselves to punishment of their own. The laws that determine the duty of protection owed to businesses and their customers is both vague and broad, making them question just how much protection...